Cite
MLA Citation
Marja-Riitta Taskinen et al.. “Efficacy and safety of alirocumab in individuals with type 2 diabetes mellitus with or without mixed dyslipidaemia: Analysis of the ODYSSEY LONG TERM trial.” Atherosclerosis, vol. 276, 2018, pp. 124–130. http://access.bl.uk/ark:/81055/vdc_100066658481.0x000059